Director of AquaLabs, Callie Seaman, discusses what needs to be done to develop the UK medical cannabis industry.
The grand opening of the clinic will expand Apollon’s patient treatment programme and generate additional revenue.
The tablets have been exported by Israel-based Panaxia Labs and European company Neuraxpharm.
The three-year agreement will see AMP become the exclusive distribution partner for Australia-based Little Green Pharma.
The company is a medical cannabis subsidiary of Greenrise Global Brands.
A collaboration will see studies undertaken to prove the efficacy and safety of the device.
The company is one of five to be selected as part of the Dutch Government’s medical cannabis cultivation trial.
Sativa Learning is launching is new medical cannabis course developed with The Medical Cannabis Clinicians Society.
MGC Pharma is assessing ArtemiC Support.
Glass Pharms will begin the domestic supply of medical cannabis in the UK from the world's first carbon-negative cannabis cultivation facility.